A trial of mithramycin in the treatment of advanced malignant disease

. 1966 Jun;20(2):256–263. doi: 10.1038/bjc.1966.32

A trial of mithramycin in the treatment of advanced malignant disease.

PMCID: PMC2008976 PMID: 5329342

These references are in PubMed. This may not be the complete list of references from this article.

BROWN J. H., KENNEDY B. J. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS. N Engl J Med. 1965 Jan 21;272:111–118. doi: 10.1056/NEJM196501212720301. [DOI] [PubMed] [Google Scholar]
KARNOFSKY D. A., BURCHENAL J. H., ARMISTEAD G. C., Jr, SOUTHAM C. M., BERNSTEIN J. L., CRAVER L. F., RHOADS C. P. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. doi: 10.1001/archinte.1951.03810040002001. [DOI] [PubMed] [Google Scholar]
KOFMAN S., MEDREK T. J., ALEXANDER R. W. MITHRAMYCIN IN THE TREATMENT OF EMBRYONAL CANCER. Cancer. 1964 Jul;17:938–948. doi: 10.1002/1097-0142(196407)17:7<938::aid-cncr2820170714>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
SPEAR P. W. Clinical trial with mithramycin. Cancer Chemother Rep. 1963 May;29:109–110. [PubMed] [Google Scholar]